PLTR vs TNXP · P/E 584, rev $4.48B vs rev $10.1M
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported TNXP revenue for 2024-12-31 was $10.1M. Net income was -$130.0M. Revenue was up 29.9% from 2023-12-31 to 2024-12-31. TNXP currently screens at market cap $194.5M.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the PLTR and TNXP stock pages for the full models.
Not investment advice.